Blood and urine cadmium, blood pressure, and hypertension: A systematic review and meta-analysis

Environmental Health Perspectives

Volumn 118, Issue 12, 2010, Pages 1676-1684

  Gallagher, Carolyn M ^a   Meliker, Jaymie R ^a,b  

^a STONY BROOK UNIVERSITY MEDICAL CENTER   (United States)

^b STONY BROOK UNIVERSITY   (United States)

Author keywords

Blood; Blood pressure; Cadmium; Hypertension; Meta analysis; Smoking; Systematic review; Urine

Indexed keywords

CADMIUM;

BLOOD LEVEL; CONCENTRATION RESPONSE; DIASTOLIC BLOOD PRESSURE; ENVIRONMENTAL EXPOSURE; HUMAN; HYPERTENSION; POPULATION RESEARCH; PREMENOPAUSE; PRIORITY JOURNAL; REVIEW; SMOKING; SYSTEMATIC REVIEW; SYSTOLIC BLOOD PRESSURE; URINE LEVEL;

ADOLESCENT; ADULT; AGED; BLOOD PRESSURE; CADMIUM; ENVIRONMENTAL EXPOSURE; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 78650286458     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.1002077     Document Type: Review

References (58)

1. ATSDR (Agency for Toxic Substances and Disease Registry). 2008. Public Health Statement for Cadmium. Available: http://www.atsdr.cdc.gov/phs/phs.asp?id=46&tid=15 [accessed 6 September 2009].
2. Barr DB, Wilder LC, Caudill S P, Gonzalez AJ, Needham LL, Pirkel JL. 2005. Urinary creatinine concentrations in the U.S. population: implications for urinary biologic monitoring measurements. Environ Health Perspect 113:192-200.
3. Benowitz NL, Sharp DS. 1989. Inverse relation between serum cotinine concentration and blood pressure in cigarette smokers. Circulation 80(5):1309-1312.
4. Berlin A, Alessio L, Sesana G, Dell'Orto A, Ghezzi I. 1985. Problems concerning the usefulness of adjustment of urinary cadmium for creatinine and specifc gravity. Int Arch Occup Environ Health 55(2):107-111.
5. Carretero OA, Oparil S. 2000. Essential hypertension. Part I: defnition and etiology. Circulation 101(3):329-335.
6. Dillon HK, Ho MH, eds. 1991. Biological Monitoring of Exposure to Chemicals: Metals. New York:John Wiley and Sons.
7. European Food Safety Authority. 2009. Scientifc opinion, cadmium in food. EFSA J 980:1-139.
8. Eum K, Lee M, Paek D. 2008. Cadmium in blood and hypertension. Sci Total Environ 407(1):147-153.
9. Everett CJ, Frithsen IL. 2008. Association of urinary cadmium and myocardial infarction. Environ Res 106(2):284-286.
10. Gallagher CM, Moonga BS, Kovach JS. 2010. Cadmium, follicle-stimulating hormone, and effects on bone in women age 42-60 years, NHANES III. Environ Res 110(1):105-111.
11. Ghasemi A, Syedmoradi L, Momenan AA, Zahediasl S, Azizi F. 2010. The influence of cigarette and qalyan (hookah) smoking on serum nitric oxide metabolite concentrations. Scand J Clin Lab Invest 70(2):116-121.
12. Green MS, Jucha E, Luz Y. 1986. Blood pressure in smokers and nonsmokers: epidemiologic findings. Am Heart J 111(5):932-940.
13. Guallar E, Silbergeld EK, Navas-Acien A, Malhotra S, Astor BC, Sharrett AR, et al. 2006. Confounding of the relation between homocysteine and peripheral arterial disease by lead, cadmium, and renal function. Am J Epidemiol 163(8):700-708.
14. Hill AB. 1965. The environment and disease: association or causation? Proc R Soc Med 58(5):295-300.
15. Ilhan N, Kucuksu M, Kaman D, Ilhan N, Ozbay Y. 2008. The 677 C/T MTHFR polymorphism is associated with essential hypertension, coronary artery disease, and higher homo-cysteine levels. Arch Med Res 39(1):125-130.
16. Järup L, Akesson A. 2009. Current status of cadmium as an environmental health problem. Toxicol Appl Pharmacol 238(3):201-208.
17. Järup L, Berglund M, Elinder CG, Nordberg G, Vahter M. 1998. Health effects of cadmium exposure-a review of the literature and a risk estimate. Scand J Work Environ Health 24(suppl 1):1-51.
18. Järup L, Rogenfelt A, Elinder CG, Nogawa K, Kjellström T. 1983. Biological half-time of cadmium in the blood of workers after cessation of exposure. Scand J Work Environ Health 9(4):327-331.
19. Kotsis V, Stabouli S, Toumanidis S, Papamichael C, Lekakis J, Germanidis G, et al. 2008. Target organ damage in "white coat hypertension" and "masked hypertension". Am J Hypertens 21(4):393-399.
20. Kundi M. 2006. Causality and the interpretation of epidemio-logic evidence. Environ Health Perspect 114:969-974.
21. Kurihara I, Kobayashi E, Suwazono Y, Uetani M, Inaba T, Oishiz M. 2004. Association between exposure to cadmium and blood pressure in Japanese peoples. Arch Environ Health 59(12):711-716.
22. Lee HY. 2008. Prevalence and risk factors of masked hypertension identifed by multiple self-blood pressure measurement [Letter]. Hypertension 52:1-2.
23. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis PA, et al. 2009. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med 6(7); doi: 10.1371/journal.pmed.1000100 [Online 21 July 2009].
24. Lin JL, Lu FH, Yeh KH. 1995. Increased body cadmium burden in Chinese women without smoking and occupational exposure. J Toxicol Clin Toxicol 33(6):639-644.
25. Littell JH, Corcoran J, Pillai V. 2008. Systematic Reviews and Meta-Analysis. New York: Oxford University Press.
26. Malpas SC. 2010. Sympathetic nervous system overactivity and its role in the development of cardiovascular disease. Physiol Rev 90(2):513-557.
27. Menditto A, Chiodo F, Patriarca M, Morisi G, Menotti A, Spagnolo A, NRF Project Research Group. 1998. Blood cadmium levels in nonexposed male subjects living in the Rome area: relationship to selected cardiovascular risk factors. Microchem J 59(1):173-179.
28. Menke A, Muntner P, Silbergeld EK, Platz EA, Guallar E. 2009. Cadmium levels in urine and mortality among U.S. adults. Environ Health Perspect 117:190-196.
29. Nakagawa H, Nishijo M. 1996. Environmental cadmium exposure, hypertension and cardiovascular risk. J Cardiovasc Risk 3(1):11-17.
30. Navas-Acien A, Selvin E, Sharrett AR, Calderon-Aranda E, Silbergeld E, Guallar E. 2004. Lead, cadmium, smoking, and increased risk of peripheral arterial disease. Circulation 109(25):3196-3201.
31. Nishijo M, Satarug S, Honda R, Tsuritani I, Aoshima K. 2004. The gender differences in health effects of environmental cadmium exposure and potential mechanisms. Mol Cell Biochem 255(1-2):87-92.
32. O'Brien E. 2008. Ambulatory blood pressure measurement: the case for implementation in primary care. Hypertension 51(6):1435-1441.
33. Paksy K, Rajczy K, Forgács Z, Lázár P, Bernard A, Gáti I, et al. 1997. Effect of cadmium on morphology and steroidogen-esis of cultured human ovarian granulose cells. J Appl Toxicol 17(5), 321-327.
34. Peters JL, Perlstein TS, Perry MJ, McNeely E, Weuve J. 2010. Cadmium exposure in association with history of stroke and heart failure. Environ Res 110(2):199-206.
35. Pizent A, Jurasovie J, Telisman S. 2001. Blood pressure in relation to dietary calcium intake, alcohol consumption, blood lead, and blood cadmium in female nonsmokers. J Trace Elem Med Biol 15(2-3):123-130.
36. Primatesta P, Falaschette E, Gupta S, Marmot MG, Poulter NR. 2001. Association between smoking and blood pressure: evidence from the health survey for England. Hypertension 37(2):187-193.
37. Puri VN, Saha S. 2003. Comparison of acute cardiovascular effects of cadmium and captopril in relation to oxidant and angiotensin converting enzyme activity in rats. Drug Chem Toxicol 26(3):213-218.
38. Reuben SH. 2010. Reducing Environmental Cancer Risk: What We Can Do Now. 2008-2009 Annual Report, President's Cancer Panel. Bethesda, MD:National Institutes of Health, National Cancer Institute.
39. Riaz K, Ahmed A. 2010. Hypertensive Heart Disease. Available: http://emedicine.medscape.com/article/162449-print [accessed 16 May 2010].
40. Rosner B. 2006. Fundamentals of Biostatistics. 6th ed. Belmont, CA:Thomson-Brooks/Cole.
41. Rothman KJ, Poole C. 2007. Some guidelines on guidelines; they should come with expiration dates. Epidemiology 18(6):794-796.
42. Satarug S, Nishijo M, Ujjin P, Vanavanitkum Y, Moore MR. 2005. Cadmium-induced nephropathy in the development of high blood pressure. Toxicol Lett 157(1):57-68.
43. Schutte R, Nawrot T, Richart T, Thijs L, Roels HA, Van Bortel LM, et al. 2008. Arterial structure and function and environmental exposure to cadmium. Occup Environ Med 65(6):412-419.
44. Staessen J, Amery A, Bernard A, Bruaux P, Buhet J P, Bulpitt CJ, et al. 1991. Blood pressure, the prevalence of cardiovascular diseases, and exposure to cadmium: a population study. Am J Epidemiol 134(3):257-267.
45. Staessen J, Bulpitt CJ, Roels H, Bernard A, Fagard R, Joossens JV, et al. 1984. Urinary cadmium and lead concentrations and their relation to blood pressure in a population with low exposure. Br J Ind Med 41(2):241-248.
46. Staessen JA, Kuznetsova T, Roels HA, Emelianov D, Fagard R. 2000. Exposure to cadmium and conventional and ambulatory blood pressures in a prospective population study. Am J Hypertens 13(2):146-156.
47. Stolarz K, Staessen JA, Kuznetasova T, Tikhonoff V, State D, Babenu S, et al. 2003. Host and environmental determinants of heart rate and heart rate variability in four European populations. J Hypertens 21(3):525-535.
48. Sutoo D, Akiyama K. 2000. Effect of cadmium or magnesium on calcium-dependent central function that reduces blood pressure. Arch Toxicol 74(1):1-4.
49. Telisman S, Jurasovic J, Pizent A, Cuitkovic P. 2001. Blood pressure in relation to biomarkers of lead, cadmium, copper, zinc, and selenium in men without occupational exposure to metals. Environ Res 87(2):57-68.
50. Tellez-Plaza M, Navas-Acien A, Craincanu CM, Guallar E. 2008. Cadmium exposure and hypertension in the 1999- 2004 National Health and Nutrition Examination Survey (NHANES). Environ Health Perspect 116:51-56.
51. Tsai JL, Horng PH, Hwang TJ, Hsu JW, Horng CJ. 2004. Determination of urinary trace elements (arsenic, copper, manganese, zinc, selenium) in patients with blackfoot disease. Arch Environ Health 59(12):686-692.
52. Tsalev DL. 1995. Atomic Absorption Spectrometry in Occupational and Environmental Health Practice. Vol 3. Progress in Analytical Methodology. Boca Raton, FL:CRC Press.
53. U.S. Department of Health and Human Services. 2000. Healthy People 2010: Understanding and Improving Health. 2nd ed. Washington, DC:U.S. Government Printing Offce.
54. Vivoli G, Bergomi M, Borella P, Fantuzzi G, Caselgrandi E. 1989. Cadmium in blood, urine, and hair related to human hypertension. J Trace Elem Electrolytes Health Dis 3(3):139-145.
55. Whittemore AS, DiCiccio Y, Provenzano G. 1991. Urinary cadmium and blood pressure: Results from the NHANES II Survey. Environm Health Perspect 91:133-140.
56. World Health Organization. 2009. Cardiovascular diseases. Fact Sheet No. 317. Available: http://www.who.int/mediacentre/factsheets/fs317/en/index.html [accessed 21 September 2009].
57. Yoopan N, Watcharasit P, Wongsawatkul O, Piyachaturawat P, Satayavivad J. 2008. Attenuation of eNOS expression in cadmium-induced hypertensive rats. Toxicol Lett 176(2):157-161.
58. Zanchetti A, Julius S, Kjeldsen S, McInnes GT, Hua T, Weber M, et al. 2006. Outcomes in subgroups of hypertensive patients treated with regimens based on valsartan and amlodipine: an analysis of fndings from the VALUE trial. J Hypertens 24(11):2163-2168.